OBJECTIVEA method for the determination of dissolution of fenofibrate chewable tablets in vitro was established.

目的:建立非诺贝特咀嚼片体外溶出度试验测定方法.

互联网

The effect of fenofibrate on amputation risk was independent of dyslipidemia and glycemic control.

非诺贝特对于截肢风险的作用独立于血脂紊乱及高血糖的控制.

互联网

Now, investigators report the effects of fenofibrate on FIELD's tertiary endpoint of nontraumatic lower - limb amputations.

现在调查报告了非诺贝特在FIELD试验中第三终点即非创伤性 低位 截肢的效果.

互联网

Fenofibrate solid dispersion tablets were prepared by solvent melting method using PEG 4000 and sodium lauryl sulfate.

以PEG4000和十二烷基硫酸钠为载体,采用溶剂-熔融法制备了非诺贝特固体分散体,再与适当辅料混合压片制得非诺贝特固体分散片.

互联网